ITTO20040329A1 - Uso di una composizione farmaceutica per il trattamento di patologie derivate da infezione da herpes virus, papilloma virus,hepatitis virus, nevralgie di origine virale, displasie di origine virale, displasie di origine virale, forme virali per immun - Google Patents

Uso di una composizione farmaceutica per il trattamento di patologie derivate da infezione da herpes virus, papilloma virus,hepatitis virus, nevralgie di origine virale, displasie di origine virale, displasie di origine virale, forme virali per immun

Info

Publication number
ITTO20040329A1
ITTO20040329A1 IT000329A ITTO20040329A ITTO20040329A1 IT TO20040329 A1 ITTO20040329 A1 IT TO20040329A1 IT 000329 A IT000329 A IT 000329A IT TO20040329 A ITTO20040329 A IT TO20040329A IT TO20040329 A1 ITTO20040329 A1 IT TO20040329A1
Authority
IT
Italy
Prior art keywords
viral origin
dysplasia
viral
virus
diseases
Prior art date
Application number
IT000329A
Other languages
English (en)
Inventor
Franco Deraco
Original Assignee
Franco Deraco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Franco Deraco filed Critical Franco Deraco
Priority to IT000329A priority Critical patent/ITTO20040329A1/it
Publication of ITTO20040329A1 publication Critical patent/ITTO20040329A1/it
Priority to EP05010726A priority patent/EP1627663A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT000329A 2004-05-18 2004-05-18 Uso di una composizione farmaceutica per il trattamento di patologie derivate da infezione da herpes virus, papilloma virus,hepatitis virus, nevralgie di origine virale, displasie di origine virale, displasie di origine virale, forme virali per immun ITTO20040329A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000329A ITTO20040329A1 (it) 2004-05-18 2004-05-18 Uso di una composizione farmaceutica per il trattamento di patologie derivate da infezione da herpes virus, papilloma virus,hepatitis virus, nevralgie di origine virale, displasie di origine virale, displasie di origine virale, forme virali per immun
EP05010726A EP1627663A3 (en) 2004-05-18 2005-05-18 Use of a pharmaceutical composition for the treatment of pathologies derived from infection by herpes virus, papillomavirus, hepatitis virus, viral neuralgia, viral dsyplasia, immune-deficiency-induced viral infections and viral neuritis.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000329A ITTO20040329A1 (it) 2004-05-18 2004-05-18 Uso di una composizione farmaceutica per il trattamento di patologie derivate da infezione da herpes virus, papilloma virus,hepatitis virus, nevralgie di origine virale, displasie di origine virale, displasie di origine virale, forme virali per immun

Publications (1)

Publication Number Publication Date
ITTO20040329A1 true ITTO20040329A1 (it) 2004-08-18

Family

ID=34936625

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000329A ITTO20040329A1 (it) 2004-05-18 2004-05-18 Uso di una composizione farmaceutica per il trattamento di patologie derivate da infezione da herpes virus, papilloma virus,hepatitis virus, nevralgie di origine virale, displasie di origine virale, displasie di origine virale, forme virali per immun

Country Status (2)

Country Link
EP (1) EP1627663A3 (it)
IT (1) ITTO20040329A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784142A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种甲硫氨酸片的制备方法
CN104784141A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种甲硫氨酸片组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497800A (en) * 1982-07-06 1985-02-05 Mead Johnson & Company Stable liquid diet composition
US5292773A (en) * 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
CA2078019C (en) * 1991-09-13 2002-08-27 Siegbert Heinrich Bissbort Substance or composition and uses thereof
AU2000231423A1 (en) * 2000-03-03 2001-09-12 Shu-Wen Lee Specific therapeutic composition for treating aids

Also Published As

Publication number Publication date
EP1627663A3 (en) 2006-03-15
EP1627663A2 (en) 2006-02-22

Similar Documents

Publication Publication Date Title
NO2017005I1 (no) Human pappilomavirus vaksine [type 6, 11, 16, 18, 31, 33, 45, 52, 58]
EA200500584A1 (ru) Нуклеозидные производные для лечения инфекционных заболеваний, вызванных вирусом гепатита c
CL2007003250A1 (es) Compuestos derivados de isoquinolina, inhibidores del virus de hepatitis c; composicion farmaceutica; y uso para el tratamiento de una infeccion por vhc.
DE60040727D1 (de) Menschliche papillomavirus impfstoff-formulierungen
DE60215157D1 (de) Verwendungen von antiviralen nucleosid-derivaten zur herstellung eines medikaments zur behandlung von hepatitis c infektionen
WO2007038507A3 (en) Modified 4'-nucleosides as antiviral agents
EP1603590A4 (en) INFLUENZA VIRUS VACCINE
DE60036952D1 (de) Influenzavirus-impfstoffzusammensetzung zur nasalen anwendung
JP2009511595A5 (it)
CL2009000305A1 (es) Compuestos derivados de 2-aril-sustituido-1-benzofurano-3-carboxamida, inhibidores de la polimerasa ns5b; composicion farmaceutica; y su uso en el tratamiento de una enfermedad causada por el virus de la hepatitis c (hcv).
JP2009535352A5 (it)
BRPI0812738A2 (pt) Composto, sal farmceuticamente aceitável, composição farmacêutica, uso de um composto, e, método par ao tratamento de uma infecção viral em um humano
UY27466A1 (es) Métodos y composiciones para el tratamiento de hepatitis c virus con 4'-modificaciones nucleosides
NO20044326L (no) Virus lignende partikler (VLP) fra human papilloma virus (HPV)
BRPI0507675A (pt) derivados de 2'-c-metil nucleosìdeo
CY1111552T1 (el) Χρηση hpv16 και hpv18 ως εμβολιο εναντι ενος ή περισσοτερων ογκογονικου hpv τυπου 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
IS7830A (is) Bóluefni gegn lifrarbólgu C veiru (HCV)
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
FR15C0084I2 (fr) Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
PT1299395E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes provocadas por virus
JP2006507295A5 (it)
ITRM20020562A1 (it) Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
ATE392903T1 (de) Impfstoff gegen pferdeherpesvirus
AU2003294757A8 (en) Formulations useful against hepatitis c virus infections